SoftBank^®

This feature includes an interface for bedside transfusion devices like SCC’s SoftID.Tx^®, improving the accuracy of patient identification.

SoftBank improves the efficiency of daily workflows for transfusion services with features like online worksheets, which enable batch processing of specimens and modification of blood products. It also provides users with the option of automatically interpreting results. With this feature, the system makes an interpretation based on the results and compares them with a logic table. In addition, SoftBank is easy to use for both technologists on the bench and supervisors monitoring daily operations.

SoftBank generates management reports to assist transfusion services in meeting their quality requirements. This feature supports multiple facilities with online tools like a supervisor’s review of daily activities, including test results, daily QC measures and exception reports. Managers can also use their time more effectively with features like audit trails and daily traces, which monitor activities and changes.

SoftBank allows multiple users to perform tasks on a single patient simultaneously during trauma situations, increasing patient safety. This feature combines the unit selection and issuing processes to provide products for a patient in a timely manner.

Users can track various products, including blood, cellular therapy, breast milk, and their derivatives, from receipt to final disposition. They can also deliver these products manually or in an electronic format, along with reports on online utilization, inventory, and product history.

SoftBank enables users to print and verify ISBT-compliant labels when modifying blood products. It can also send ISBT labels to a third-party labeling company via an interface.

SoftBank tracks and maintains an inventory of supplies used by a transfusion service. Users can also document the supply that was used during component modification. In addition, SoftBank allows users to safely add returned or unused products to inventory.

Users can link newborns to their mothers with the mother’s Medical Record Number (MRN). SoftBank allows users to check the blood type of newborns and their mother’s blood type when selecting and dispensing products. It also keeps neonatal specimens valid for up to 120 days without requiring additional testing or cross-matches for qualifying specimens.

SoftBank provides crisp, clear displays with an improved interface called WebScape. This new product uses colorful icons to facilitate navigation, along with accentuated options that allow users to easily identify their location. WebScape also displays demographics in a ribbon format that makes patient information easy to read.

Users have the option of selecting blood and derived products based on their preferences when filling patient orders. For example, they can select units by scanning the physical unit number with a bar code reader or selecting the unit number from a list. Once users select the product, they can print labels and transfusion slips, provided it doesn’t require a cross-match.

Users can manually enter results into a centralized database. This option facilitates results testing, thus increasing efficiency by streamlining the workflow.